Xconomy’s Digital Events →
TG Therapeutics is developing drugs to treat B-cell disorders such as non-Hodgkin’s lymphoma and rheumatoid arthritis.
From Our Partners · Special Report
Advice for funding and future transformational opportunities
From Our Editors · Podcast
Becoming the Cell & Gene Therapy Hub
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.